Flow cytometry analysis of infiltrating T-cell subsets in tumors showed that treating tumors i.t. with either or both agents did not influence the density of T-cells (Fig. 6d) in the TME nor the activation of T-cell subsets in both the tumor and lymphoid organs apart from enrichment of KLRG1+ effector T-cells in the spleen and tumor of VSVΔ51-treated animals (Fig. S11). Here, KLRG1 is linked to neoplasm.